Nancy Chu

Nancy Chu is a Senior Director in Patient Safety at Gilead Sciences, where they have served since 2001. They previously held the position of Director, Head of Drug Safety Operations at Iovance Biotherapeutics, Inc. from 2016 to 2017, and worked as a Senior Drug Safety Associate at Scios from 2002 to 2003. Nancy earned a Bachelor’s degree in Biology from the University of California, Berkeley, and a Master’s degree in Nursing from San Francisco State University.